In contrast, the COVID-19 vaccines containing N1mψ-modified mRNA, formulated in LNPs containing either MC3 (BioNTech) or SM-102 (Moderna), were able to induce IL-1β in human PBMCs. The gene discussed is IL1B; the disease is COVID-19.